Company intelligence / Profile preview
Provident Pharmaceuticals
Greeceprovidentpharma.gr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Provident Pharmaceuticals commercializes generic and branded drugs (niche/legacy) mainly in Greece, Cyprus, and South Eastern Mediterranean, under multiple brand names and strengths; products are in use, not investigational.
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyNeurologyMetabolic DisordersHematologyPsychiatry
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Manufacturing and distribution contracts with Cosmos Health
Beyond the preview
Go deeper on Provident Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Provident Pharmaceuticals.